Patent Yard Sign in
Expired European patentEurope

USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1

EP 1017385 B1 · Applicant: Sanofi-Synthélabo

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 20, 1998 and granted July 16, 2003. A European patent lasts at most 20 years from filing, so its term ended May 20, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by November 20, 2023.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMay 20, 1998
PublishedJuly 12, 2000
GrantedJuly 16, 2003
Term endedMay 20, 2018
Application numberEP 98925747
Classification (CPC)A61P1/00 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedMay 20, 1998PublishedJuly 12, 2000Patent grantedJuly 16, 2003Term endedMay 20, 2018

Sources & verification